Cardia Bioplastics Limited
Myeco Group Ltd, together with its subsidiaries, develops, manufactures, and sells sustainable packaging materials in Oceanic, Asia, the United States, Europe, and Africa. The company supplies biodegradable and compostable resins, packaging products, and cast films to blue-chip companies. It manufactures and distributes polyethylene films, renewable resources resins, and finished products. The co… Read more
Cardia Bioplastics Limited (SCGRF) - Net Assets
Latest net assets as of June 2024: $14.03 Million USD
Based on the latest financial reports, Cardia Bioplastics Limited (SCGRF) has net assets worth $14.03 Million USD as of June 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($18.05 Million) and total liabilities ($4.02 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $14.03 Million |
| % of Total Assets | 77.74% |
| Annual Growth Rate | 7.02% |
| 5-Year Change | 23.37% |
| 10-Year Change | N/A |
| Growth Volatility | 69.58 |
Cardia Bioplastics Limited - Net Assets Trend (2019–2024)
This chart illustrates how Cardia Bioplastics Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Cardia Bioplastics Limited (2019–2024)
The table below shows the annual net assets of Cardia Bioplastics Limited from 2019 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-06-30 | $14.03 Million | -39.33% |
| 2023-06-30 | $23.13 Million | -13.26% |
| 2022-06-30 | $26.67 Million | -8.73% |
| 2021-06-30 | $29.22 Million | +156.87% |
| 2020-06-30 | $11.38 Million | +13.81% |
| 2019-06-30 | $9.99 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Cardia Bioplastics Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1777305500.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $47.92 Million | 341.48% |
| Total Equity | $14.03 Million | 100.00% |
Cardia Bioplastics Limited Competitors by Market Cap
The table below lists competitors of Cardia Bioplastics Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
FARMACOSMO SPA O.N.
F:ZJ1
|
$13.90 Million |
|
Domo Activos Socimi SA
MC:DOMO
|
$13.90 Million |
|
Metalicity Limited
STU:P8O
|
$13.90 Million |
|
Freja eID Group AB
ST:FREJA
|
$13.91 Million |
|
Van Phat Hung Corp
VN:VPH
|
$13.89 Million |
|
Willbes
KO:008600
|
$13.89 Million |
|
Rigel Resource Acquisition Corp.
OTCGREY:RRACF
|
$13.89 Million |
|
Tribeca Resources Corporation
PINK:TRRCF
|
$13.88 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Cardia Bioplastics Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 23,133,000 to 14,034,000, a change of -9,099,000 (-39.3%).
- Net loss of 9,327,000 reduced equity.
- Other factors increased equity by 228,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-9.33 Million | -66.46% |
| Other Changes | $228.00K | +1.62% |
| Total Change | $- | -39.33% |
Book Value vs Market Value Analysis
This analysis compares Cardia Bioplastics Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.13x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 1.80x to 2.13x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-06-30 | $0.03 | $0.05 | x |
| 2020-06-30 | $0.03 | $0.05 | x |
| 2021-06-30 | $0.05 | $0.05 | x |
| 2022-06-30 | $0.05 | $0.05 | x |
| 2023-06-30 | $0.04 | $0.05 | x |
| 2024-06-30 | $0.02 | $0.05 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Cardia Bioplastics Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -66.46%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -64.55%
- • Asset Turnover: 0.80x
- • Equity Multiplier: 1.29x
- Recent ROE (-66.46%) is below the historical average (-25.08%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | -41.72% | -20.00% | 1.43x | 1.46x | $-5.17 Million |
| 2020 | -10.43% | -5.64% | 1.34x | 1.38x | $-2.32 Million |
| 2021 | 8.86% | 8.61% | 0.89x | 1.16x | $-331.81K |
| 2022 | -11.57% | -9.94% | 0.93x | 1.25x | $-5.75 Million |
| 2023 | -29.18% | -29.56% | 0.82x | 1.21x | $-9.06 Million |
| 2024 | -66.46% | -64.55% | 0.80x | 1.29x | $-10.73 Million |
Industry Comparison
This section compares Cardia Bioplastics Limited's net assets metrics with peer companies in the Packaging & Containers industry.
Industry Context
- Industry: Packaging & Containers
- Average net assets among peers: $2,505,488,775
- Average return on equity (ROE) among peers: -21.89%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Cardia Bioplastics Limited (SCGRF) | $14.03 Million | -41.72% | 0.29x | $13.89 Million |
| Alliance Creative Group, Inc (ACGX) | $2.12 Million | 12.57% | 1.98x | $208.71K |
| Advanced Container Technologies Inc (ACTX) | $970.86K | -145.07% | 1.77x | $670.31 |
| Ardagh Metal Packaging SA (AMBP) | $286.00 Million | -73.43% | 17.62x | $605.72 Million |
| Amcor PLC (AMCR) | $11.74 Billion | 4.35% | 2.16x | $18.72 Billion |
| Avery Dennison Corp (AVY) | $1.36 Billion | -54.80% | 2.67x | $13.11 Billion |
| Ball Corporation (BALL) | $3.30 Billion | 7.98% | 3.91x | $16.41 Billion |
| Berry Global Group Inc (BERY) | $-128.00 Million | 0.00% | 0.00x | $7.83 Billion |
| Cascades Inc (CADNF) | $1.96 Billion | 10.12% | 1.77x | $571.95 Million |
| CCL Industries Inc (CCDBF) | $3.28 Billion | 16.14% | 1.24x | $7.23 Billion |
| Crown Holdings Inc (CCK) | $3.25 Billion | 3.23% | 2.83x | $11.67 Billion |